Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study

Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study

The primary objective of this prospective, single-centre study is to establish the clinical performance characteristics of Xpert Bladder Cancer Monitor on the GeneXpert Instrument Systems in comparison to the methods currently used at the site for detecting recurrent bladder cancer.

Inclusion Criteria:

• The patient shall meet all of the following criteria in order to be considered eligible for enrollment:

  • Patient has been diagnosed with NMIBC within 24 months of enrollment
  • At the time of the enrollment visit, the patient is scheduled for a cystoscopy within the next 6 weeks of enrollment

Exclusion Criteria:

• Patient has had an excision procedure or BCG treatment within six weeks (42 days) before enrollment.